YANRU WANG is the lead sponsor of 4 current clinical trials in our China register. 2 are recruiting patients now. The most common phase is Phase EARLY_PHASE1. The most-studied condition is Autoimmune Diseases.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases
NCT06318533 · ClinicalTrials.gov ↗ · Autoimmune Diseases
|
Phase EARLY_PHASE1 | Recruiting | 2024-03 | China |
|
A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
NCT06976437 · ClinicalTrials.gov ↗ · B Cell Lymphoma, Multiple Myeloma
|
Phase EARLY_PHASE1 | Recruiting | 2025-05 | China |
|
A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
NCT07316920 · ClinicalTrials.gov ↗ · Relapsed/Refractory B-cell Lymphoma
|
Phase 1 | Not yet open | 2025-12 | China |
|
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
NCT07316907 · ClinicalTrials.gov ↗ · Hematologic Malignancies, Lymphoma
|
Phase 1 | Not yet open | 2025-12 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 4 | 2 |
A trial with sites in more than one country appears in each of those registers.
Sponsors with the most current trials registered for this condition.
YANRU WANG is the lead sponsor of 4 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.